HER2 somatic mutations are associated with poor survival in HER2‐negative breast cancers

It is well documented that human epidermal growth factor receptor 2 (HER2) overexpression/amplification is associated with poor survival in breast cancer patients. However, it is largely unknown whether HER2 somatic mutations are associated with survival in HER2‐negative breast cancer patients. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tonghui, Xu, Ye, Sheng, Shuyan, Yuan, Hua, Ouyang, Tao, Li, Jinfeng, Wang, Tianfeng, Fan, Zhaoqing, Fan, Tie, Lin, Benyao, Xie, Yuntao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406600/
https://www.ncbi.nlm.nih.gov/pubmed/28164408
http://dx.doi.org/10.1111/cas.13182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406600/
https://www.ncbi.nlm.nih.gov/pubmed/28164408
http://dx.doi.org/10.1111/cas.13182

Ejemplares similares